

Please try another search
Milestone Pharmaceuticals, Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent and short-acting calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is developing etripamil for the treatment of arrhythmias with an indication to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Name | Age | Since | Title |
---|---|---|---|
Michael John Tomsicek | 57 | 2019 | Independent Non-Executive Director |
Richard C. Pasternak | 73 | 2019 | Independent Non-Executive Director |
Daniel R. Omstead | 70 | 2017 | Observer |
Jean-Yves Le Heuzey | - | - | Member of the Scientific Advisory Board |
Harry A. Kopelman | - | - | Member of the Scientific Advisory Board |
Debra K. Liebert | 66 | 2015 | Independent Non-Executive Director |
John Camm | - | - | Member of the Scientific Advisory Board |
Lisa M. Giles | 64 | 2020 | Independent Non-Executive Director |
Joseph G. Oliveto | 55 | 2017 | CEO, President & Director |
John DiMarco | - | - | Member of the Scientific Advisory Board |
Robert James Wills | 69 | 2020 | Independent Chairman of the Board |
Albert L. Waldo | - | - | Member of the Scientific Advisory Board |
Harry Jefferson Leighton | 77 | - | Member of the Scientific Advisory Board |
Paul Dorian | - | - | Member of the Scientific Advisory Board |
Peter R. Kowey | - | - | Member of the Scientific Advisory Board |
Seth H. Z. Fischer | 67 | 2023 | Independent Non-Executive Director |
Philippe Douville | 61 | 2005 | Founder, Strategic Advisor & Member of Scientific Advisory Board |
Philip T. Sager | 67 | 2020 | Chief Medical Advisor & Member of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review